Neuroderm logo

NDRM - Neuroderm News Story

$38.85 0.0  0.0%

Last Trade - 17/10/17

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 7386

Japan's Mitsubishi Tanabe Pharma to buy Israel's Neuroderm for $1.1 bln

Mon 24th July, 2017 7:27am
TOKYO, July 24 (Reuters) - Japan's Mitsubishi Tanabe Pharma 
Corp  4508.T  said on Monday it will acquire Israeli drug maker 
Neuroderm  NDRM.O  for $1.1 billion in an all-cash deal to 
expand its overseas business.   
     
 
 (Reporting by Sam Nussey; Editing by Muralikumar Anantharaman) 
 ((sam.nussey@thomsonreuters.com; +81364411596; Reuters 
Messaging: sam.nussey.thomsonreuters.com@reuters.net)) 
 
Keywords: NEURODERM M&A/MITSUB TANABE
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.